BioCentury
ARTICLE | Company News

Basilea, Grupo Biotoscana deal

September 19, 2016 7:00 AM UTC

Basilea granted Grupo Biotoscana exclusive rights to commercialize Cresemba isavuconazole and Zevtera ceftobiprole in 19 Latin American countries, including Argentina, Brazil, Columbia and Mexico. B...